Article Text

Download PDFPDF
Extended report
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
  1. Rohit Aggarwal1,
  2. Elaine Cassidy1,
  3. Noreen Fertig1,
  4. Diane Carol Koontz1,
  5. Mary Lucas1,
  6. Dana P Ascherman2,
  7. Chester V Oddis1
  1. 1Department of Medicine, Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
  2. 2Department of Medicine, Division of Rheumatology, University of Miami, Miami, Florida, USA
  1. Correspondence to Dr Rohit Aggarwal, Department of Medicine, Division of Rheumatology, University of Pittsburgh School of Medicine, Falk Medical Building, Suite 2B, 3601 Fifth Avenue, Pittsburgh, PA 15213, USA;aggarwalr{at}upmc.edu
  2. RA and EC contributed equally to the manuscript and are co-first authors.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.